Back to Blog

Safety · August 2025

Recognizing Vascular Occlusion: Early Signs & Emergency Protocol

A practical, life-saving framework every aesthetic injector should memorize before treating patients — because minutes matter when a vascular complication occurs.

KS

Karina Seuser, FNP

Lead Instructor, Injector Academy Training

Critical Safety Information

This article is for educational purposes and should be part of your broader safety training. It does not replace hands-on emergency protocol training or institutional guidelines. Every injector should have hyaluronidase on hand and know their emergency protocol before treating any patient.

Vascular occlusion is the most serious complication in aesthetic injectable treatments. While rare — occurring in an estimated 0.001% to 0.01% of filler treatments — the consequences can be devastating if not recognized and treated immediately. This guide provides a practical framework for early recognition and emergency response.

Types of Vascular Occlusion

Intra-Arterial Injection

Filler is injected directly into an artery. This can cause immediate ischemia and, if retinal arteries are involved via retrograde flow, can lead to vision loss. Immediate blanching, severe pain disproportionate to injection, and livedo reticularis are classic signs.

Extrinsic Compression

Large-volume filler placement compresses nearby vessels from the outside. Onset may be more gradual than intra-arterial injection and presents with progressive pain, blanching, and capillary refill delay in the affected territory.

Early Signs: The "STOP" Mnemonic

S

Severe Pain

Pain disproportionate to the injection, often described as burning or intense — distinct from typical injection discomfort.

T

Tissue Blanching

Immediate or rapid whitening of the skin in the vascular distribution pattern, often with well-demarcated borders.

O

Obvious Color Changes

Livedo reticularis (purple, net-like mottling), dusky discoloration, or blue-gray appearance of the skin.

P

Prolonged Capillary Refill

Capillary refill time greater than 2-3 seconds in the affected area. Compare bilaterally for reference.

Emergency Response Protocol

Immediate Action Required

  1. 1

    STOP injecting immediately

    Do not inject more filler. Do not massage the area aggressively — this can worsen ischemia.

  2. 2

    Administer high-dose hyaluronidase NOW

    Standard emergency dose: 150-500 units injected directly into and throughout the affected area. In periocular cases or suspected retinal involvement, higher doses (500-1500 IU) may be warranted. Do not wait for confirmation — time is tissue.

  3. 3

    Apply warm compresses and nitroglycerin paste if available

    Heat and vasodilation can help improve blood flow while hyaluronidase takes effect.

  4. 4

    Mark the affected area and photograph

    Document the initial presentation and serial photographs every 15-30 minutes to track progression or improvement.

  5. 5

    Escalate care immediately

    For suspected ophthalmic artery occlusion: immediate transfer to emergency department with ophthalmology consultation. Time-to-treatment is critical — retinal ischemia becomes irreversible in approximately 90 minutes.

"In my courses, I tell every student: if you can't recognize a vascular occlusion within 30 seconds and start your emergency protocol within 60, you're not ready to inject independently. This isn't about fear — it's about respect for the responsibility we carry."

— Karina Seuser, FNP

Prevention: Best Practices

  • Aspirate before every injection and wait 5-10 seconds. While aspiration is not 100% reliable, it remains an important safety step.

  • Use cannulas in high-risk areas such as the glabella, nasal region, and tear trough. Cannulas significantly reduce (but do not eliminate) the risk of intra-arterial injection.

  • Inject slowly with low pressure and use small aliquots (0.05-0.1 mL per injection). High-pressure, rapid injection increases the risk of intravascular placement.

  • Know your anatomy intimately — particularly the facial artery, angular artery, dorsal nasal artery, and supratrochlear/supraorbital vessels. Vascular mapping should be second nature.

  • Maintain hyaluronidase stock — check expiration dates monthly. Store reconstituted product per manufacturer guidelines and have a clear dosing protocol posted in your treatment room.

Safety Is the Foundation of Everything We Teach

Complication prevention and emergency management are covered extensively in every Injector Academy course. Learn vascular anatomy, aspiration technique, and emergency protocols in a supervised clinical setting before treating independently.

View Our Courses